Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03390920 · ClinicalTrials.gov registry record · NA
Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions
A NA study, sponsored by R3 Stem Cell.
- Not yet
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT03390920 is a NA study that has not yet begun recruiting, run by R3 Stem Cell. The registered enrollment target is 200 participants.
The verdict
NCT03390920, a NA study, has not yet begun recruiting, sponsored by R3 Stem Cell.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.
Interventions
- OTHER Umbilical Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2030-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03390920
The ClinicalTrials.gov registry entry for NCT03390920 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is R3 Stem Cell, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Umbilical Allograft is the first listed.
NCT03390920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03390920 about?
NCT03390920 is a clinical study titled "Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions". The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.
What is the current status of trial NCT03390920?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-01-01. Estimated completion is 2030-01-01.
What interventions are being tested in trial NCT03390920?
The interventions under investigation include: Umbilical Allograft (OTHER).
Who is sponsoring clinical trial NCT03390920?
This trial is sponsored by R3 Stem Cell, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.